Abstract-The angiotensin II type 2 (AT 2 ) receptor is upregulated in pathological conditions such as vascular injury and exerts antagonistic effects against AT 1 receptor-mediated actions. We examined the possibility that the sex difference in vascular remodeling is associated with altered AT 2 receptor expression, which is located on the X chromosome. In this study, we examined this possibility by using AT 2 receptor-null (Agtr2Ϫ) mice. Vascular injury was induced by polyethylene cuff placement around the femoral artery of wild-type (Agtr2ϩ) and Agtr2Ϫ mice. In Agtr2ϩ mice, AT 2 receptor expression in the injured artery was enhanced, and this increase was greater in female than in male mice, with no significant difference in AT 1 receptor expression between male and female mice. Increases in neointimal formation, DNA synthesis, expression of monocyte chemoattractant protein-1, production of superoxide anion, and NADPH oxidase activity in the injured artery were attenuated in female compared with male mice. These parameters were augmented in Agtr2Ϫ mice, whereas the sex differences in these parameters were smaller in Agtr2Ϫ than in Agtr2ϩ mice. Treatment with a nonhypotensive dose of the AT 1 receptor blocker valsartan decreased these parameters significantly in Agtr2ϩ mice, and these inhibitory effects of valsartan were greater in female mice. This sex difference in valsartan's inhibitory effect was less marked in Agtr2Ϫ mice. Our results suggest that the sex difference in response to vascular injury could be at least partially attributed to the exaggerated AT 2 receptor expression in the injured vessel in female mice. Key Words: angiotensin II Ⅲ inflammation Ⅲ oxidative stress Ⅲ receptors, angiotensin Ⅲ remodeling R ecent evidence has revealed that actions of the angiotensin (Ang) II receptor subtypes AT 1 and AT 2 are mutually antagonistic. 1,2 The AT 2 receptor is abundantly and widely expressed in fetal tissues, but its expression declines rapidly after birth. 3,4 Interestingly, the AT 2 receptor is reexpressed in certain pathological conditions such as inflammation and vascular injury. 1,2 These findings suggest that the AT 2 receptor plays an important role not only in vasculogenesis but also in vascular remodeling.The effect of AT 1 receptor blockers (ARBs) may not be entirely due to the blockade of the AT 1 receptor. When the AT 1 receptor is blocked, increased Ang II may act on the AT 2 receptor, which could be involved in the effects of the ARB. The AT 2 receptor plays a role in the pathogenesis of cardiovascular and renal diseases. However, the results, though suggestive, are sometimes equivocal. A more extensive knowledge of the AT 2 receptor could therefore contribute to the understanding of the clinical benefits of ARBs. We have previously reported that the AT 2 receptor exerts antiinflammatory and antiproliferative effects by counteracting the AT 1 receptor in the process of neointimal formation after vascular injury in a mouse model of vascular disease induced by polyethylene cuff placement. 5,...